Position
Fidelity in Corcept Therapeutics Inc
Back to the book · All holders of CORT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $148.8M$40.31 → $86.95
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.41M | $84M | — | — | — | 0.0% |
| Q1 2026 | 3.19M | $128.6M | $40.31 | $13.3M | $31.3M | 0.0% |
| Q2 2026 | 3.34M | $290.2M | $86.95 | $148.8M | $12.8M | 0.0% |